Document is current
Any future updates will be listed below
-
Authors
Hess, Annika
Renko, Alexandra
Schäfer, Andreas
Jung, Mira
Fraccarollo, Daniela
Schmitto, Jan D.
Diekmann, Johanna
Thum, Thomas
Bengel, Frank M.
Bauersachs, Johann
Thackeray, James T.
Tillmanns, Jochen https://orcid.org/0000-0001-9429-5484
-
Funding
Funding for this research was provided by:
nextGENERATION Medical Scientist Program Hannover Medical School (2002_EKMK.13)
Deutsche Forschungsgemeinschaft (TH2161/3-1)
Fondation Leducq (ImmunoFib)
Medizinische Hochschule Hannover (MHH)
- License Information
-
More Information
Article History
Received: 1 November 2024
Revised: 18 January 2025
Accepted: 18 February 2025
First Online: 3 March 2025
Declarations
:
: TT is founder and CSO/CMO of Cardior Pharmaceuticals GmbH, a wholly owned subsidiary of Novo Nordisk A/S.
